Why Danaher Corporation (DHR) stock moved
No significant move on Nov 18, 2026 (+1.2%, close-to-close). Latest notable session: Nov 5, 2026.
Why Danaher Corporation (DHR) fell 3.7% on November 5, 2026
Danaher Corporation (DHR) fell 3.7% on November 5, 2026, closing at $226.34 versus $234.93 the prior session (close-to-close, from daily closes). We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred on elevated volume (1.7x the 5-day average) while peer healthcare stocks also declined: UNH -2.16% and LLY -3.17%, suggesting a sector-wide pullback. Source: FMP price data; BestStocks detection.
Danaher Corporation (DHR) moved -4.68% from $237.45 to $226.34 on 2026-11-05. We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred on elevated volume (1.7x the 5-day average) while peer healthcare stocks also declined: UNH -2.16% and LLY -3.17%, suggesting a sector-wide pullback.
What to watch next: DHR earnings scheduled for 2026-01-27, with consensus EPS estimate of $2.49.
Earlier sessions that moved DHR
- +4.3%Danaher beat third-quarter earnings expectations, driven by strong core performance and bolstered by new AI lab collaborations with NVIDIA and announcements of an AI-powered autonomous lab at Abcam (per web sources).
- +3.0%Foster Group Inc. purchased 3,232 shares.
- −2.5%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
- +3.3%After MassMutual Private Wealth & Trust FSB increased its stake in the company.
- −4.4%Julie Sawyer Montgomery became President and CEO effective that date.
- +3.0%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
- −3.1%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Danaher Corporation (DHR) shares rose 1.2% to $228.41 as of November 19, 2026, a modest gain from the prior close of $225.77. BestStocks flagged the session as a major change for DHR. Below, we break down what changed for DHR, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
DHR climbed 1.2% to $228.41
DHR CEO Julie Sawyer Montgomery scheduled to present at UBS and Jefferies healthcare conferences November 9. Investor conferences provide platform for management to discuss strategy, guidance, and answer analyst questions directly.
What it means for Danaher Corporation investors
For Danaher Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 1.2% session move; Positive price momentum. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Because peers moved similarly, the shift looks more macro- or sector-driven than a change in DHR's fundamentals. Wall Street's consensus price target sits at $244.63, implying +7.1% upside from $228.41. BestStocks rates the overall signal quality weak (36/100). With earnings roughly 69 days out, the next report is the most likely near-term test of the move.
DHR price reaction
DHR last traded at $228.41, up $2.64 (+1.17%) from the previous close of $225.77. The session traded on 0.6× average volume (below avg), so participation was unremarkable. Its healthcare peer group moved a median -2.3% over the same stretch, leaving DHR ahead of the group by 3.5 points. Over the past month the stock has ranged between $224.24 and $236.98, and it currently sits about 33% of the way up that band.
Bullish and bearish analyst opinions on Danaher Corporation (DHR)
The consensus analyst price target on Danaher Corporation (DHR) is $244.63, 7.1% above the recent $228.41. Over the past 90 days analysts logged 0 upgrades, 11 maintains, and 0 downgrades. Here is how the bullish and bearish cases on DHR line up.
The bullish case
- Wall Street's consensus price target of $244.63 implies +7.1% upside from $228.41.
- The Street's most bullish target is $275.00 (+20.4%).
- Positive 1.2% session move.
- Positive price momentum.
The bearish case
- The most bearish analyst target is $195.00 (-14.6%).
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 19, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for DHR
In-depth DHR event analyses
Frequently asked questions about DHR
Why did Danaher Corporation (DHR) stock move?
Danaher Corporation (DHR) fell 3.7% on November 5, 2026, closing at $226.34 versus $234.93 the prior session (close-to-close, from daily closes). We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred on elevated volume (1.7x the 5-day average) while peer healthcare stocks also declined: UNH -2.16% and LLY -3.17%, suggesting a sector-wide pullback. Source: FMP price data; BestStocks detection.
How much did DHR stock rise?
DHR gained 1.17% ($2.64) versus the prior close of $225.77, last trading at $228.41 on 0.6× average volume.
When is Danaher Corporation's next earnings date?
DHR's next earnings report is estimated for 2027-01-27 — about 69 days away.
What is the analyst price target for DHR?
The consensus analyst price target for DHR is $244.63, about 7.1% above the current $228.41. Over the past 90 days, analysts recorded 0 upgrades, 11 maintains, and 0 downgrades.
Is the DHR move company-specific or sector-wide?
BestStocks classifies it as a sector-wide move: the peer group moved a median -2.3% against DHR's +1.2%. DHR ranks top 1 of 7 peers.
How BestStocks tracks DHR
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared DHR-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for DHR, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 19, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

